730 related articles for article (PubMed ID: 18158116)
1. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion.
Horibe EK; Sacks J; Unadkat J; Raimondi G; Wang Z; Ikeguchi R; Marsteller D; Ferreira LM; Thomson AW; Lee WP; Feili-Hariri M
Transpl Immunol; 2008 Feb; 18(4):307-18. PubMed ID: 18158116
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression.
Ikeguchi R; Sacks JM; Unadkat JV; Solari M; Horibe EK; Thomson AW; Lee AW; Feili-Hariri M
Transplantation; 2008 Jan; 85(2):237-46. PubMed ID: 18212629
[TBL] [Abstract][Full Text] [Related]
3. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
[TBL] [Abstract][Full Text] [Related]
4. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological modification of dendritic cells to promote their tolerogenicity in transplantation.
Turnquist HR; Fischer RT; Thomson AW
Methods Mol Biol; 2010; 595():135-48. PubMed ID: 19941109
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance.
Turnquist HR; Raimondi G; Zahorchak AF; Fischer RT; Wang Z; Thomson AW
J Immunol; 2007 Jun; 178(11):7018-31. PubMed ID: 17513751
[TBL] [Abstract][Full Text] [Related]
7. A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier.
Koch U; Choksi S; Marcucci L; Korngold R
J Immunol; 1998 Jul; 161(1):421-9. PubMed ID: 9647252
[TBL] [Abstract][Full Text] [Related]
8. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection.
Zhang X; Li M; Lian D; Zheng X; Zhang ZX; Ichim TE; Xia X; Huang X; Vladau C; Suzuki M; Garcia B; Jevnikar AM; Min WP
Clin Immunol; 2008 Jun; 127(3):313-21. PubMed ID: 18358783
[TBL] [Abstract][Full Text] [Related]
9. Injection of donor-derived OX62+ splenic dendritic cells with anti-CD4 monoclonal antibody generates CD4+CD25+FOXP3+ regulatory T cells that prolong allograft skin survival indefinitely and abrogate production of donor-specific antibodies in a rat model.
Alawieh M; Rifle G; Bouchot O; Malapert G; Mousson C; Martin L
Transplant Proc; 2009 Oct; 41(8):3363-6. PubMed ID: 19857750
[TBL] [Abstract][Full Text] [Related]
10. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
[TBL] [Abstract][Full Text] [Related]
11. Intrinsic ability of GM+IL-4 but not Flt3L-induced rat dendritic cells to promote allogeneic T cell hyporesponsiveness.
Taieb A; Breitinger JJ; Unadkat JV; Shufesky WJ; Morelli AE; Thomson AW; Lee WP; Feili-Hariri M
Clin Immunol; 2007 May; 123(2):176-89. PubMed ID: 17276735
[TBL] [Abstract][Full Text] [Related]
12. Use of rapamycin in the induction of tolerogenic dendritic cells.
Fischer R; Turnquist HR; Taner T; Thomson AW
Handb Exp Pharmacol; 2009; (188):215-32. PubMed ID: 19031028
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment with triptolide and rapamycin prolongs graft survival in a mouse model of cardiac transplantation.
Liu Y; Chen Y; Liu FQ; Lamb JR; Tam PK
Transpl Int; 2008 May; 21(5):483-94. PubMed ID: 18266776
[TBL] [Abstract][Full Text] [Related]
14. [Impact of novel negative immunoregulatory dendritic cells on regulatory T cells in cardiac allograft recipient rats].
Zheng DH; Shi BY; Zou YP; Cai M; Qian YY; Hong BF; Dou LP; Li L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jan; 26(1):13-7. PubMed ID: 20056079
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4.
Hall BM; Fava L; Chen J; Plain KM; Boyd RA; Spicer ST; Berger MF
J Immunol; 1998 Nov; 161(10):5147-56. PubMed ID: 9820484
[TBL] [Abstract][Full Text] [Related]
16. Immature rat myeloid dendritic cells generated in low-dose granulocyte macrophage-colony stimulating factor prolong donor-specific rat cardiac allograft survival.
DePaz HA; Oluwole OO; Adeyeri AO; Witkowski P; Jin MX; Hardy MA; Oluwole SF
Transplantation; 2003 Feb; 75(4):521-8. PubMed ID: 12605121
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
[TBL] [Abstract][Full Text] [Related]
18. Indirect allorecognition in acquired thymic tolerance: induction of donor-specific tolerance to rat cardiac allografts by allopeptide-pulsed host dendritic cells.
Garrovillo M; Ali A; Oluwole SF
Transplantation; 1999 Dec; 68(12):1827-34. PubMed ID: 10628758
[TBL] [Abstract][Full Text] [Related]
19. A tolerogenic semimature dendritic cells induce effector T-cell hyporesponsiveness by activation of antigen-specific CD4+CD25+ T regulatory cells that promotes skin allograft survival in mice.
Fu BM; He XS; Yu S; Hu AB; Zhang J; Ma Y; Tam NL; Huang JF
Cell Immunol; 2010; 261(1):69-76. PubMed ID: 20038461
[TBL] [Abstract][Full Text] [Related]
20. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival.
Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B
J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
